Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research

In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Shi, Pujiang, Yeong, Wai Yee, Laude, Augustinus, Tan, Edgar Yong Sheng
Other Authors: School of Mechanical and Aerospace Engineering
Format: Article
Language:English
Published: 2018
Subjects:
Online Access:https://hdl.handle.net/10356/85384
http://hdl.handle.net/10220/45150
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-85384
record_format dspace
spelling sg-ntu-dr.10356-853842023-03-04T17:12:00Z Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research Shi, Pujiang Yeong, Wai Yee Laude, Augustinus Tan, Edgar Yong Sheng School of Mechanical and Aerospace Engineering Singapore Centre for 3D Printing Retina Bioprinting In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 cells and Y79 cell-laden bioink to ensure homogeneous ARPE-19 cell seeding; subsequently, two distinctive Y79 cell-seeding patterns were bioprinted on top of the ARPE-19 cell monolayer. The bioprinted ARPE-19 cells were evaluated by prestoblue assay, F-actin, and hematoxylin/eosin (HE) staining, and then the cells were observed under laser scanning and invert microscopy for 14 days. The Y79 cells in alginate/pluronic bioink after bioprinting had been closely monitored for 7 days. Live/dead assay and scanning electrical microscopy (SEM) were employed to investigate Y79 cell viability and morphology. Both the ARPE-19 and Y79 cells were in excellent condition, and the successfully bioprinted retina model could be utilized in drug delivery, disease mechanism and treatment method discoveries. Published version 2018-07-20T02:47:54Z 2019-12-06T16:02:50Z 2018-07-20T02:47:54Z 2019-12-06T16:02:50Z 2017 Journal Article Shi, P., Tan, E. Y. S., Yeong, W. Y., & Laude, A. (2017). Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research. International Journal of Bioprinting, 3(2), 138-146. https://hdl.handle.net/10356/85384 http://hdl.handle.net/10220/45150 10.18063/IJB.2017.02.008 en International Journal of Bioprinting © 2017 The Author(s) (International Journal of Bioprinting) (published by Whioce Publishing Pte Ltd). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 9 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Retina
Bioprinting
spellingShingle Retina
Bioprinting
Shi, Pujiang
Yeong, Wai Yee
Laude, Augustinus
Tan, Edgar Yong Sheng
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
description In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 cells and Y79 cell-laden bioink to ensure homogeneous ARPE-19 cell seeding; subsequently, two distinctive Y79 cell-seeding patterns were bioprinted on top of the ARPE-19 cell monolayer. The bioprinted ARPE-19 cells were evaluated by prestoblue assay, F-actin, and hematoxylin/eosin (HE) staining, and then the cells were observed under laser scanning and invert microscopy for 14 days. The Y79 cells in alginate/pluronic bioink after bioprinting had been closely monitored for 7 days. Live/dead assay and scanning electrical microscopy (SEM) were employed to investigate Y79 cell viability and morphology. Both the ARPE-19 and Y79 cells were in excellent condition, and the successfully bioprinted retina model could be utilized in drug delivery, disease mechanism and treatment method discoveries.
author2 School of Mechanical and Aerospace Engineering
author_facet School of Mechanical and Aerospace Engineering
Shi, Pujiang
Yeong, Wai Yee
Laude, Augustinus
Tan, Edgar Yong Sheng
format Article
author Shi, Pujiang
Yeong, Wai Yee
Laude, Augustinus
Tan, Edgar Yong Sheng
author_sort Shi, Pujiang
title Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
title_short Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
title_full Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
title_fullStr Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
title_full_unstemmed Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
title_sort hybrid three-dimensional (3d) bioprinting of retina equivalent for ocular research
publishDate 2018
url https://hdl.handle.net/10356/85384
http://hdl.handle.net/10220/45150
_version_ 1759854343341735936